相似文献
1
Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs.
BMJ. 2003 Jul 5;327(7405):18-22. doi: 10.1136/bmj.327.7405.18.
2
Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy.
Br J Clin Pharmacol. 2016 Jul;82(1):238-48. doi: 10.1111/bcp.12938. Epub 2016 Apr 27.
3
The role of non-steroidal anti-inflammatory drugs in acute liver injury.
BMJ. 1992 Oct 10;305(6858):865-8. doi: 10.1136/bmj.305.6858.865.
4
Effects of the European restrictive actions concerning nimesulide prescription: a simulation study on hepatopathies and gastrointestinal bleedings in Italy.
Ann Ist Super Sanita. 2010;46(2):153-7. doi: 10.4415/ANN_10_02_08.
5
Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy.
Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):365-75. doi: 10.1002/pds.3385. Epub 2012 Dec 11.
6
Serious liver injury induced by Nimesulide: an international collaborative study.
Arch Toxicol. 2021 Apr;95(4):1475-1487. doi: 10.1007/s00204-021-03000-8. Epub 2021 Mar 24.
7
Fatal hepatoxicity secondary to nimesulide.
Eur J Clin Pharmacol. 2001 Jul;57(4):321-6. doi: 10.1007/s002280100312.
8
Nimesulide-induced hepatitis and acute liver failure.
Isr Med Assoc J. 1999 Oct;1(2):89-91.
9
Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication.
Dig Liver Dis. 2010 Feb;42(2):143-8. doi: 10.1016/j.dld.2009.06.009. Epub 2009 Jul 21.
10
Nimesulide-induced acute hepatotoxicity.
Indian J Gastroenterol. 2003 Nov-Dec;22(6):239.
引用本文的文献
1
Case Report: Genetic predisposition to low-dose NSAID-induced liver injury in real-world China.
Front Med (Lausanne). 2025 Jul 24;12:1637289. doi: 10.3389/fmed.2025.1637289. eCollection 2025.
2
Drug-Induced Liver Injury-Pharmacological Spectrum Among Children.
Int J Mol Sci. 2025 Feb 25;26(5):2006. doi: 10.3390/ijms26052006.
3
Mass balance, metabolic disposition, and pharmacokinetics of a single IV dose of [14C]CA102N in HT-29 xenograft athymic nude mice.
Front Pharmacol. 2024 Dec 5;15:1440679. doi: 10.3389/fphar.2024.1440679. eCollection 2024.
4
Ibuprofen alters epoxide hydrolase activity and epoxy-oxylipin metabolites associated with different metabolic pathways in murine livers.
Sci Rep. 2021 Mar 29;11(1):7042. doi: 10.1038/s41598-021-86284-1.
5
Validity of cerebrovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project.
PLoS One. 2020 Jan 9;15(1):e0227653. doi: 10.1371/journal.pone.0227653. eCollection 2020.
6
A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project.
PLoS One. 2019 Jul 8;14(7):e0218919. doi: 10.1371/journal.pone.0218919. eCollection 2019.
7
Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: A study in three European data sources.
Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):965-975. doi: 10.1002/pds.4803. Epub 2019 Jun 6.
8
Comparison of Early Effectiveness of Three Different Intervention Methods in Patients with Chronic Orofacial Pain: A Randomized, Controlled Clinical Trial.
Pain Res Manag. 2019 Mar 11;2019:7954291. doi: 10.1155/2019/7954291. eCollection 2019.
9
Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources.
CNS Drugs. 2019 Apr;33(4):383-395. doi: 10.1007/s40263-019-00611-9.
10
Nimesulide-induced hepatotoxicity: A systematic review and meta-analysis.
PLoS One. 2019 Jan 24;14(1):e0209264. doi: 10.1371/journal.pone.0209264. eCollection 2019.
本文引用的文献
1
Hepatotoxicity associated with nimesulide: data from the Spanish Pharmacovigilance System.
Clin Pharmacol Ther. 2002 Nov;72(5):596-7.
2
Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area.
Drug Saf. 2001;24(14):1081-90. doi: 10.2165/00002018-200124140-00006.
3
Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs.
Am J Med. 2001 Feb 19;110 Suppl 3A:20S-7S. doi: 10.1016/s0002-9343(00)00682-3.
4
Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s.
Arch Intern Med. 2000 Jul 24;160(14):2093-9. doi: 10.1001/archinte.160.14.2093.
5
Ketorolac use in outpatients and gastrointestinal hospitalization: a comparison with other non-steroidal anti-inflammatory drugs in Italy.
Eur J Clin Pharmacol. 1998 Jul;54(5):393-7. doi: 10.1007/s002280050481.
6
Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs.
Arch Intern Med. 1998 Jan 12;158(1):33-9. doi: 10.1001/archinte.158.1.33.
7
Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs.
Arthritis Rheum. 1997 Feb;40(2):201-8. doi: 10.1002/art.1780400204.
8
Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors.
Arch Intern Med. 1994 Feb 14;154(3):311-6. doi: 10.1001/archinte.1994.00420030117012.
9
Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.
J Clin Epidemiol. 1993 Nov;46(11):1323-30. doi: 10.1016/0895-4356(93)90101-6.
10
Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs.
Epidemiology. 1995 Jan;6(1):49-54. doi: 10.1097/00001648-199501000-00010.
Zotero 插件